Catheter-Related Bloodstream Infection

Surgical Clinics of North America

Volumn 89, Issue 2, 2009, Pages 463-474

  Goede, Matthew R ^a   Coopersmith, Craig M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacteremia; Catheter related bloodstream infection; Central venous catheter; Infection; Intensive care unit; Morbidity

Indexed keywords

ALCOHOL; CHLORHEXIDINE; MINOCYCLINE; POVIDONE IODINE; RIFAMPICIN; SULFADIAZINE;

ANTIBIOTIC THERAPY; ANTISEPSIS; BACTERIAL COLONIZATION; CATHETER INFECTION; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; CENTRAL VENOUS PRESSURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COST BENEFIT ANALYSIS; COST OF ILLNESS; ECHOCARDIOGRAPHY; EDUCATION PROGRAM; HOSPITAL COST; HUMAN; HYGIENE; INTENSIVE CARE; LENGTH OF STAY; MORTALITY; PARENTERAL NUTRITION; PATIENT CARE; PHYSICAL EXAMINATION; PREVENTION AND CONTROL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; RISK FACTOR; SILVER IMPREGNATION; SKIN DECONTAMINATION;

ANTI-INFECTIVE AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; CATHETERIZATION, CENTRAL VENOUS; CROSS INFECTION; EQUIPMENT CONTAMINATION; HUMANS; HYGIENE; SEPSIS;

EID: 61549093770     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2008.09.003     Document Type: Review

References (57)

1. Medicare program: changes to the hospital inpatient prospective payment systems and fiscal year 2008 rates. Fed Regist 72 (2007) 47379-47428
2. O'Grady N.P., Alexander M., Dellinger E.P., et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 51 (2002) 1-29
3. Warren D.K., Quadir W.W., Hollenbeak C.S., et al. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med 34 (2006) 2084-2089
4. Higuera F., Rosenthal V.D., Duarte P., et al. The effect of process control on the incidence of central venous catheter-associated bloodstream infections and mortality in intensive care units in Mexico. Crit Care Med 33 (2005) 2022-2027
5. Digiovine B., Chenoweth C., Watts C., et al. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 160 (1999) 976-981
6. Diekema D.J., Beekmann S.E., Chapin K.C., et al. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol 41 (2003) 3655-3660
7. Rosenthal V.D., Guzman S., and Orellano P.W. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay. Am J Infect Control 31 (2003) 291-295
8. Dimick J.B., Pelz R.K., Consunji R., et al. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 136 (2001) 229-234
9. Edwards J.R., Peterson K.D., Andrus M.L., et al. National Healthcare Safety Network (NHSN) Report, data summary for 2006, issued June 2007. Am J Infect Control 35 (2007) 290-301
10. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 27 (1999) 520-532
11. Pearson M.L. Guideline for prevention of intravascular device-related infections. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 17 (1996) 438-473
12. Farkas J.C., Liu N., Bleriot J.P., et al. Single- versus triple-lumen central catheter-related sepsis: a prospective randomized study in a critically ill population. Am J Med 93 (1992) 277-282
13. Goldmann D. System failure versus personal accountability: the case for clean hands. N Engl J Med 355 (2006) 121-123
14. Albert R.K., and Condie F. Hand-washing patterns in medical intensive-care units. N Engl J Med 304 (1981) 1465-1466
15. Jenner E.A., Fletcher B.C., Watson P., et al. Discrepancy between self-reported and observed hand hygiene behaviour in healthcare professionals. J Hosp Infect 63 (2006) 418-422
16. Maury E., Alzieu M., Baudel J.L., et al. Availability of an alcohol solution can improve hand disinfection compliance in an intensive care unit. Am J Respir Crit Care Med 162 (2000) 324-327
17. Maki D.G., Ringer M., and Alvarado C.J. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 338 (1991) 339-343
18. Humar A., Ostromecki A., Direnfeld J., et al. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis 31 (2000) 1001-1007
19. Chaiyakunapruk N., Veenstra D.L., Lipsky B.A., et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 136 (2002) 792-801
20. Chaiyakunapruk N., Veenstra D.L., Lipsky B.A., et al. Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine. Clin Infect Dis 37 (2003) 764-771
21. Bleasdale S.C., Trick W.E., Gonzalez I.M., et al. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 167 (2007) 2073-2079
22. Raad I.I., Hohn D.C., Gilbreath B.J., et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 15 (1994) 231-238
23. Mermel L.A., McCormick R.D., Springman S.R., et al. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 91 (1991) 197S-205S
24. Hu K.K., Veenstra D.L., Lipsky B.A., et al. Use of maximal sterile barriers during central venous catheter insertion: clinical and economic outcomes. Clin Infect Dis 39 (2004) 1441-1445
25. Merrer J., De Jonghe B., Golliot F., et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 286 (2001) 700-707
26. Maki D.G., Stolz S.S., Wheeler S., et al. A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management. Crit Care Med 22 (1994) 1729-1737
27. Ho K.M., and Litton E. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J Antimicrob Chemother 58 (2006) 281-287
28. Sherertz R. Look before you leap: discontinuation of an infusion therapy team. Infect Control Hosp Epidemiol 20 (1999) 99-100
29. bi-Said D., Raad I., Umphrey J., et al. Infusion therapy team and dressing changes of central venous catheters. Infect Control Hosp Epidemiol 20 (1999) 101-105
30. Gillies D., O'Riordan L., Wallen M., et al. Optimal timing for intravenous administration set replacement. Cochrane Database Syst Rev (2005) CD003588
31. Garland J.S., Alex C.P., Henrickson K.J., et al. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. Pediatrics 116 (2005) e198-e205
32. van D.W., and van Woensel J.B. Prophylactic antibiotics for preventing early central venous catheter gram positive infections in oncology patients. Cochrane Database Syst Rev (2007) CD003295
33. Jaffer Y., Selby N.M., and Taal M.W. Meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis 51 (2008) 233-241
34. Jardine L.A., Inglis G.D., Davies M.W., et al. Prophylactic systemic antibiotics to reduce morbidity and mortality in neonates with central venous catheters. Cochrane Database Syst Rev (2008) CD006179
35. Coopersmith C.M., Rebmann T.L., Zack J.E., et al. Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit. Crit Care Med 30 (2002) 59-64
36. Eggimann P., Harbarth S., Constantin M.N., et al. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 355 (2000) 1864-1868
37. Berenholtz S.M., Pronovost P.J., Lipsett P.A., et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 32 (2004) 2014-2020
38. Pronovost P., Needham D., Berenholtz S., et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 355 (2006) 2725-2732
39. Eyer S., Brummitt C., Crossley K., et al. Catheter-related sepsis: prospective, randomized study of three methods of long-term catheter maintenance. Crit Care Med 18 (1990) 1073-1079
40. Cobb D.K., High K.P., Sawyer R.G., et al. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med 327 (1992) 1062-1068
41. Cook D., Randolph A., Kernerman P., et al. Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med 25 (1997) 1417-1424
42. Crnich C.J., and Maki D.G. Are antimicrobial-impregnated catheters effective? When does repetition reach the point of exhaustion?. Clin Infect Dis 41 (2005) 681-685
43. Hockenhull J.C., Dwan K., Boland A., et al. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. Health Technol Assess 12 (2008) 1-154
44. Veenstra D.L., Saint S., and Sullivan S.D. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 282 (1999) 554-560
45. Schuerer D.J., Zack J.E., Thomas J., et al. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial. Surg Infect (Larchmt) 8 (2007) 445-454
46. Veenstra D.L., Saint S., Saha S., et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 281 (1999) 261-267
47. Darouiche R.O., Raad II, Heard S.O., et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 340 (1999) 1-8
48. Kalfon P., de V.C., Samba D., et al. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients. Crit Care Med 35 (2007) 1032-1039
49. Fraenkel D., Rickard C., Thomas P., et al. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. Crit Care Med 34 (2006) 668-675
50. Fowler Jr. V.G., Li J., Corey G.R., et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 30 (1997) 1072-1078
51. Fan S.T., Teoh-Chan C.H., and Lau K.F. Evaluation of central venous catheter sepsis by differential quantitative blood culture. Eur J Clin Microbiol Infect Dis 8 (1989) 142-144
52. Raad I., Hanna H.A., Alakech B., et al. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med 140 (2004) 18-25
53. Mermel L.A., Eggimann P., Harbarth S., et al. Prevention of intravascular catheter-related infections Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 355 (2000) 1864-1868
54. Mermel L.A., Farr B.M., Sherertz R.J., et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32 (2001) 1249-1272
55. Crowley A.L., Peterson G.E., Benjamin Jr. D.K., et al. Venous thrombosis in patients with short- and long-term central venous catheter-associated Staphylococcus aureus bacteremia. Crit Care Med 36 (2008) 385-390
56. Rello J., Coll P., and Prats G. Evaluation of culture techniques for diagnosis of catheter-related sepsis in critically ill patients. Eur J Clin Microbiol Infect Dis 11 (1992) 1192-1193
57. Leibovici L., Paul M., Poznanski O., et al. Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study. Antimicrob Agents Chemother 41 (1997) 1127-1133